Phosphoric acid, methyl ester, compd. with guanidine(85153-69-1)
- Name: Phosphoric acid, methyl ester, compd. with guanidine
- Synonyms:
- Molecular Formula:C2H10N3O4P
- Molecular Weight:171.0923
- CAS Registry Number:85153-69-1
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.85153-69-1 Phosphoric acid, methyl ester, compd. with guanidine
Assay:98%Min Appearance:detailed in specifications Package:according to the clients requirement Storage:Store in dry, dark and ventilated place. Transportation:by air or by ocean shipping Application:An important raw material and intermediate used in Organic Synthesis, Pharmaceuticals
Min. Order:1Kilogram
Supplier:Dayang Chem (Hangzhou) Co.,Ltd. [
China (Mainland)] CAS No.85153-69-1 Phosphoric acid, methyl ester, compd. with guanidine
Assay:99% Transportation:By sea Application:Pharmaceutical industry
Min. Order:0
Supplier:Antimex Chemical Limied [
China (Mainland)] CAS No.85153-69-1 Phosphoric acid, methyl ester, compd. with guanidine
Assay:99% Appearance:white powder Package:drum or based on customers' requirement Storage:normal temperature storage Transportation:by sea, by air Application:We have different specifications for different applications
Min. Order:1Metric Ton
Supplier:Bluecrystal chem-union [
China (Mainland)]
Other Product
- 325-65-5/3-[2-(4-fluorophenyl)-2-oxoethyl]-5-(2-hydroxyethyl)-4-methyl-1,3-thiazol-3-ium
- 1191-91-9/2,5,8,11,14,17,20,23-Octaoxatetracosane
- 4164-43-6/1-nitro-3-[(3-nitrophenyl)methyl]benzene
- 72948-02-8/Peroxysachalinin
- 107044-92-8/Acetic acid,2-[4-[(1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene)methyl]phenoxy]-,2-[(4-hydroxyphenyl)methylene]hydrazide
- 81865-13-6/ethyl {4-[bis(2-hydroxyethyl)sulfamoyl]phenyl}carbamate
- 131575-05-8/14-methoxy-5-methylmorphinone
- 1013-66-7/3,3-dimethyl-2-phenylmorpholine
- 18217-12-4/5-METHYL-2-HEPTANONE
- 18420-71-8/N-[(R)-3,4-Dihydro-8-hydroxy-3α-methyl-1-oxo-1H-2-benzopyran-7-yl]carbonyl-L-phenylalanine ethyl ester
- 68814-88-0/Distillates, petroleum, heavy naphthenic, sulfurized
- 90954-18-0/4-oxocyclohexane-1,2-dicarboxylic acid
- 5449-93-4/2-(2-phenylethyl)pentanamide
- 149355-76-0/6H-[1]Benzopyrano[4',3':4,5]pyrrolo[2,1-a]isoquinolin-6-one,14-(3,4-dimethoxyphenyl)-8,9-dihydro-3,11-dihydroxy-2,12-dimethoxy-
- 15500-51-3/Isoquinolinium,1,2,3,4-tetrahydro-7-hydroxy-6-methoxy-1-[(4-methoxyphenyl)methyl]-2,2-dimethyl-,(1R)-
- 123064-69-7/Aconitane-6,16-diol,20-ethyl-1,14-dimethoxy-4-methyl-7,8-[methylenebis(oxy)]-, (1a,6b,14a,16b)-
- 105639-12-1/1-[5-(4,5-dihydro-1,3-oxazol-2-yl)-2-{[5-(3-methylisoxazol-5-yl)pentyl]oxy}phenyl]ethanone
- 39964-60-8/[(2Z)-3-cyclohexyl-2-(cyclohexylimino)-4-oxo-1,3-thiazolidin-5-yl]acetic acid
- 217449-23-5/3H,12H-4,1:11,8:18,15-Trinitrilo-1H-pyrrolo[2,- 1-c][1,11,18,4,7,14,21]trithiatetraazacyclotetracosine- 5,12,19,22(4H)-tetrone,6,7,13,14,17,18,- 20,21,24,25,26,26a-dodecahydro-21-(1-methylethyl)- 7-[(1S)-1-methylpropyl]-14-[2- (methylthio)ethyl]-,(4R,7S,14S,18R,21S,26aS)-
- 85153-69-1/Phosphoric acid, methyl ester, compd. with guanidine
- 15514-04-2/Thiazolium,5-(2-chloroethyl)-3-[(1,6-dihydro-2-methyl-6-oxo-5-pyrimidinyl)methyl]-4-methyl-,chloride (1:1)
- 85187-53-7/pentylpiperidine
- 66999-67-5/5-(ethylsulfanyl)[1,2,4]triazolo[4,3-a]pyridine
- 117941-62-5/(Z)-{1-[(1-cyclohexylethoxy)methyl]-3-methyl-1,3-dihydro-2H-imidazol-2-ylidene}-N-oxomethanaminium chloride
- 131077-42-4/benz(3,4)-6-oxaestra-1,3,5(10),8-tetraen-17-ol
- 136540-27-7/2,3,8,9-tetramethoxy-6,11-dimethyl-6,11-dihydro-5H-indeno[1,2-c]isoquinolin-5-one hydrochloride
- 50598-28-2/N-[3-(dimethylamino)propyl]tridecafluorohexanesulphonamide
- 22234-06-6/(3Z)-17-ethynyl-3-[(hexanoyloxy)imino]estr-4-en-17-yl acetate
- 193540-55-5/3-Cyclohexene-1-methanol,R-[(1E)-2-[(1S,3S,- 4R)-3-bromo-4-hydroxy-4-methylcyclohexyl]- 1-propenyl]-2,2-dimethyl-6-methylene-,(RR,1R)-
- 66345-13-9/4-Cyclohexyl-2,6-di(α-methylbenzyl)phenol